Tradestie Institutional Equity Comparison Engine

CRSP vs BEAM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BEAM Overall Edge

BEAM Captures Institutional Edge (3โ€“1 Pillars ยท 3โ€“7 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Beam Therapeutics Inc. Common Stock (BEAM) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CRSP counters with relative strength in Valuation. Fundamentally, CRSP trades at 23.4x Forward P/E with -2058.6% operating margin (+1325.1% YoY revenue) versus BEAM at N/M Forward P/E and -267.7% operating margin (-96.8% YoY). In options structure, CRSP sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against BEAM sits in BREAKDOWN (42nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRSP
CRSP 23.4x vs BEAM N/M Fwd P/E
Growth & Margin Winner BEAM
Op Margin -2058.6% vs -267.7% ยท YoY +1325.1% vs -96.8%
Momentum & Technical Winner BEAM
1Y -20.5% vs -1.7% ยท 52W Pos 1% vs 6%
Options & Structure Winner BEAM
BREAKDOWN (52nd %ile IV) vs BREAKDOWN (42nd %ile IV)
CRSP NASDAQ
CRISPR Therapeutics AG
Biological Products, (No Disgnostic Substances)
$40.61
-3.86% 1D
Market Cap $4.1B
1M Return -17.54%
1Y Return -20.54%
Forward P/E 23.4x
Unified AI Score
48.6 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 68.0 Mom 60.0
BEAM NASDAQ
Beam Therapeutics Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$21.29
-6.75% 1D
Market Cap $2.4B
1M Return -9.29%
1Y Return -1.71%
Forward P/E N/M
Unified AI Score
45.9 / 100 HOLD
Tech 30.0 Fund 52.0 Flow 70.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRSP -20.54% BEAM -1.71% Spread: +18.83 pp (BEAM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRSP Revenue BEAM Revenue CRSP Op. Margin BEAM Op. Margin Margin Edge
FY2018 $0M N/A -5087.8% N/A CRSP
FY2019 $290M $0M 16.1% -417522.2% CRSP
FY2020 $0M $0M -49295.5% -553166.7% CRSP
FY2021 $910M $50M 40.8% -757.0% CRSP
FY2022 $0M $60M -56190.4% -555.6% BEAM
FY2023 $370M $380M -60.0% -46.7% BEAM
FY2024 $40M $60M -1250.4% -654.3% BEAM
FY2025 $0M $140M -18933.6% -274.6% BEAM

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRSP (7) vs BEAM (3)
Institutional Metric CRSP BEAM Criterion Row Winner
Market Capitalization Scale $4.1B $2.4B Larger Scale CRSP
Trailing P/E Ratio Valuation 23.4x N/M Lower Multiple CRSP
Forward P/E Ratio Valuation 23.4x N/M Lower Multiple CRSP
Revenue Growth (YoY) Growth +1325.1% -96.8% Higher Growth CRSP
Operating Margin (TTM) Profitability -2058.6% -267.7% Higher Margin BEAM
Net Profit Margin Profitability 0.0% -73.9% Higher Margin CRSP
Return on Equity (ROE) Capital Efficiency -25.6% -11.3% Higher ROE BEAM
52-Week Range Position Momentum 1% ($40โ€“$63) 6% ($20โ€“$38) Stronger Trend BEAM
Beta / 30D Volatility Risk Regime 1.85ฮฒ ยท 60% Vol 2.24ฮฒ ยท 86% Vol Lower Realized Risk CRSP
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 45.9 / 100 (HOLD) Higher Composite CRSP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRSP vs BEAM Buy Guide
CRSP BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CRSP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BEAM BREAKDOWN
103d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 42nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BEAM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRSP nor BEAM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.